AI assistant
RESMED INC — Director's Dealing 2017
Nov 14, 2017
30071_dirs_2017-11-14_4ae78f6e-c489-4948-b07a-25e57b1a93cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-10
Reporting Person: Sodhi Rajwant (President, SaaS Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-10 | ResMed Common Stock | F | 688 | $83.06 | Disposed | 29472 | Direct |
| 2017-11-10 | ResMed Common Stock | F | 1227 | $83.06 | Disposed | 28245 | Direct |
| 2017-11-10 | ResMed Common Stock | F | 1363 | $83.06 | Disposed | 26882 | Direct |
| 2017-11-10 | ResMed Common Stock | F | 361 | $83.06 | Disposed | 26521 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.
F2: Includes 152 shares of ResMed stock purchased on October 31, 2017, through the ResMed Employee Stock Purchase Plan.
F3: Corrects misstatement of shares reported. Certified outstanding shares totaled 6,528 for grant issued 11/19/2015 prior 16-b officer status.
F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.
F5: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.
F6: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 12/16/2013.